Cingulate therapeutics llc
WebJan 7, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ... WebCingulate. Manufacturing · Kansas, United States · <25 Employees . Cingulate is a clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from freq uently diagnosed conditions …
Cingulate therapeutics llc
Did you know?
WebShane J. Schaffer founded Cingulate, Inc., Cingulate Works, Inc. and Cingulate Therapeutics LLC. Presently, Dr. Schaffer holds the position of Chairman & Chief Executive Officer for Cingulate, Inc. and Chairman & Chief Executive Officer of Cingulate Therapeutics LLC and Chairman & Chief Executive Officer of Cingulate Works, Inc. … WebThis Joint Commercialization Agreement (this “Agreement”) is made on March 7 th 2024 (the “Effective Date”) by and between Indegene, Inc., a Delaware corporation having its place of business at Suite 104, 150 College Road W, Princeton, NJ 08540 (hereinafter referred to as “Indegene”) and Cingulate Therapeutics LLC, a Delaware ...
WebExhibit 10.1 . AMENDMENT TO EMPLOYMENT AGREEMENT . This AMENDMENT is made and effective as of April 1, 2024 by and between CINGULATE THERAPEUTICS … WebMar 10, 2024 · Cingulate plans to commence two CTx-1301 Phase 3 clinical studies in 2024: (1) a fixed-dose pediatric and adolescent safety and efficacy study, which will …
WebCingulate Inc. 1,061 followers. 2mo. Today we announce our Q3 2024 financial results and provided a clinical and business update, including updated study timelines for our lead … WebCingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products.
WebJan 9, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ...
WebOct 26, 2024 · Cingulate Therapeutics, LLC is a privately-held, clinical-stage, biopharmaceutical company focused on the development of new and innovative products … fnf indie cross version 2WebApr 2, 2024 · Cingulate Therapeutics LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing the Company's innovative, precision ... fnf indie cross vs cuphead sans \u0026 bendy modWebAmendment to Employment Agreement, effective April 1, 2024, between Cingulate Therapeutics LLC and Raul R. Silva Cingulate Inc. Reports First Quarter 2024 Results and Provides Clinical and Business Update Announcement of First Subject Dosing for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ … greenup old fashion days 2017WebSep 23, 2024 · EX-10.4 3 ex10-4.htm . Exhibit 10.4 . EMPLOYMENT AGREEMENT . This AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS … greenup ohioWebCingulate currently has two (2) product candidates, CTX-1301 and CTX-1302, that are being developed to serve the approximate $18 billion annual U.S. ADHD market. A third … 10 Mar 2024 Cingulate Inc. Reports Fourth Quarter and Full Year 2024 Financial … Pipeline Overview. Cingulate® completed a proof-of-concept trial in human subjects … Cingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 … Shane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and … About Cingulate®. Cingulate® (CTx®)is a Phase 3 clinical stage … Mr. Gallagher is a Co-Founder of Cingulate Therapeutics and serves as a member … greenup pay onlineWebDec 8, 2024 · Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to … fnf indignancy midiWebAGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of August 30, 2024 by and among Cingulate Therapeutics LLC, a Delaware limited liability company (“CTx”), … fnf indie cross week piano